Add BrightSurf on Google Email

Science News for February 1, 2026


Diabetes management in disadvantaged communities improves significantly with financial incentives, study finds

A new study found that providing financial vouchers to offset medication costs can significantly improve glycemic control among patients with uncontrolled Type 2 diabetes. After six months, participants receiving performance-based incentives saw a clinically substantial reduction in HbA1c levels.

SourceThe Hebrew University of Jerusalem·JournalThe Annals of Family Medicine·TypeExperimental study·DateFeb 1, 2026

New treatment approach boosts survival in young leukaemia patients

A recent clinical trial has shown that switching part of the standard chemotherapy protocol for a targeted immunotherapy significantly improves outcomes for young people living with acute lymphoblastic leukaemia (ALL). Nearly 89% of patients are still alive and cancer-free after three years of follow-up.

SourceSAHMRI·JournalHemaSphere·TypeExperimental study·DateFeb 1, 2026

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: February 2, 2026

Researchers have developed new CXCR4-targeting radiolabeled peptides for cancer imaging and therapy, producing clear tumor images and extending survival in preclinical testing studies. Additionally, PET scans are being used to predict prostate cancer outcomes, identify primary aldosteronism, and guide treatment decisions.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateFeb 1, 2026

Better Data for Better Health: NUS Medicine and IHME launch new regional centre to tackle ageing, climate, and chronic disease risks across Southeast Asia

The NUS-IHME Global Burden of Disease Research Centre aims to bridge the gap between longevity and healthy ageing by examining the impact of extreme heat, antimicrobial resistance, and other environmental shifts. The centre will provide critical data and insights to inform health strategies across Southeast Asia.

Breakthrough in nonlinear electrophotonics: 2000%-V⁻¹ electric enhancement of nonlinear light generation using an angstrom-scale plasmonic junction

Researchers have demonstrated an angstrom-scale electroplasmonic platform enabling giant modulation (2000% V⁻¹ ) of near-field nonlinear optical effects across a broad spectral range. The discovery provides a novel scheme for highly efficient electro-optical conversion in an infinitesimal spatial scale.

SourceNational Institutes of Natural Sciences·JournalNature Communications·TypeExperimental study·DateFeb 1, 2026

Malfunction of the brain’s excitatory “brake” triggers severe epilepsy: DGIST reveals the mechanism of MDGA2

Researchers have identified MDGA2 as a causative gene for developmental and epileptic encephalopathy (DEE), a rare neurological disorder. The study highlights the potential for early diagnosis and new therapies to modulate MDGA2 function or reduce excessive excitatory signaling in the brain.

SourceDGIST (Daegu Gyeongbuk Institute of Science and Technology)·JournalAmerican Journal of Human Genetics·DateFeb 1, 2026